Lundbeck partners with Vanderbilt University on schizophrenia research project
January 10, 2018Research and Development
Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to develop a …
New project examining FDA-approved drugs for Alzheimer’s, worries over research remains
January 10, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …
Bayer and J&J successfully reverse $28 million Xarelto court payout
January 10, 2018Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma
Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …
Slow-release, once-weekly pill for HIV developed
January 10, 2018Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical
Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …
Swallowable capsules could revolutionise bowel disorder treatment
January 9, 2018Research and Development biotech, drugs, pharma, pharmaceutical
Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening …
Sri Lanka to build first-ever pharmaceutical manufacturing zone
January 9, 2018Manufacturing and Production Pharma Zone, Sri Lanka, manufacturing, pharma
Sri Lanka is set to build its first-ever exclusive pharmaceutical manufacturing zone, it has emerged. The State Pharmaceuticals Manufacturing Corporation …
Six-strong collaboration to sequence 500,000 exomes
January 9, 2018Manufacturing and Production, Research and Development UK Biobank, biotech, drugs, pharma, pharmaceutical
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of …
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Hunt resists move from health secretary position, receives expanded role
January 9, 2018Manufacturing and Production, Medical Communications Jeremy Hunt, NHS, Theresa May, biotech, drugs, pharma, pharmaceutical
As part of Theresa May’s well-publicised cabinet reshuffle, many were expecting Jeremy Hunt to move from his position as Secretary …
Ex-Genentech exec named as new Juno Therapeutics CIO
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics
Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
Sanofi and Alynylam rejig sees global rights switch-up
January 8, 2018Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
The PROs and cons of pushing patient centricity
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma
As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
FDA clears Amgen’s bone drug for multiple myeloma
January 8, 2018Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma
Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
Celgene in $7bn shot on Impact
January 8, 2018Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical
Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no
January 8, 2018Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma
It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …
Pfizer exits neuroscience R&D space
January 8, 2018Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …
Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds
January 5, 2018Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
Novartis Pharma Ex-CEO takes three roles in two days
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical
Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Top Ten most popular articles on Pharmafile.com this week
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten
Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
